Kardia 12L vs C8 Health

Cardiology and urgent care offices buying a point-of-care 12-lead ECG are AliveCor's market. Kardia 12L is listed at $2,295 (USD), and the page does not say whether that price recurs. The security page lists SOC 2 Type 2 and ISO 27001, plus ISO 42001 covering Kardia AI V2 and Corvair, and FDA records show Corvair's resting-ECG interpretation cleared in June 2024 (K231010).

C8 Health sells to a perioperative quality lead at a hospital. It is a protocol platform whose Panda AI answers only from the hospital's vetted content. The vendor states SOC 2 and HIPAA and says more than 150 institutions trust it, naming MetroHealth, Lahey and UTMB Health. A 2026 JMIR Human Factors survey of 142 MetroHealth anesthesiology clinicians measured usability, and its authors include a C8 consultant and the C8 CMO. C8 calls itself a care consistency platform for health systems, where AliveCor sells an ECG device. C8 makes no FDA claim, and openFDA shows no clearance under its name.